Transcarent Stock
Transcarent is a health technology company that aims to simplify access to high-quality, affordable healthcare for individuals and organizations. Founded to address the complexities of the healthcare system, Transcarent provides a comprehensive platform that combines benefits navigation, clinical guidance, and care delivery.
Sign up for SecondMarket™ to view the market and buy or sell Transcarent Stock
Buy + SellTranscarent Funding
Sign up to gain insights into Transcarent funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Mar 07, 2024 | Series D | 125.80M | ||
| Jan 27, 2022 | Series C | 8.75M | ||
| Jan 11, 2022 | Series C | 200.00M | ||
| Jun 10, 2021 | Series B | 58.00M | ||
| Nov 19, 2020 | Series A | 46.40M | ||
| Jun 17, 2020 | Series Seed | 3.37M |
See Transcarent Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Transcarent Stock Valuation + Share Prices
View real-time Tape D™ data on Transcarent stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Transcarent Management Team
Chief Strategy Officer
Caitlin Fleming
Chief Financial Officer
Stephanie Peng
Chief Medical Officer
Randy Hawkins
Chief Technology Officer
Praful Kaul
Chief Operating Officer
Snezana Mahon
CEO, Director
Glen Tullman
Chief Innovation Officer
Jeff Dobro
Chief Marketing Officer
Janine Gianfredi
Director
David Calone
Director
Peter Hudson
Director
Lee Shapiro
Transcarent Major Investors
Jove Equity Partners LLC
Alta Partners
Merck Global Health Innovation Fund LLC
Leaps by Bayer
Intermountain Healthcare Innovation Fund
7wire Ventures
GreatPoint Ventures
Ally Bridge Group
Kinnevik
Threshold Ventures
Kleiner Perkins Caufield & Byers LLC (KPCB)
Human Capital
General Catalyst Partners LLC
Learn More About Transcarent Stock
Buy Transcarent Stock
01Transcarent stock does not trade on public stock exchanges. Transcarent stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Transcarent stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Transcarent Stock
02Transcarent Stock does not trade on public stock exchanges. In order to sell Transcarent shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Transcarent Stock Price
03Transcarent does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Transcarent share price and other valuable private market data.
Read more about secondary market private company stock prices:
Transcarent Stock Ticker Symbol
04There is no ticker symbol for Transcarent stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Transcarent Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Transcarent stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Transcarent Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Transcarent stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Transcarent Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Transcarent IPO
08Transcarent is a private company and has not had an IPO. There is currently no Transcarent IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Transcarent IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Transcarent Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
